Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
SMTI
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
globenewswire.comPOSITIVO
The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—FBRX, LXFR, SMTI, and MKTX
NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2…
Halper Sadeh LLC is Investigating Whether FBRX, LXFR, SMTI, MKTX are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to…
Halper Sadeh LLC is Investigating Whether MKTX, SMTI, LNTH are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm to…
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)
BALA CYNWYD, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Acker…
Top Biotech Gainers: SPRC On Watch, AVTR, NEO Boost Full-Year Outlook, SMTI Scooped Up
(RTTNews) - Today's top biotech gainers include SciSparc, after its subsidiary successfully completed internal validation of a proprietary quantum sampling platform designed to analyze clinical trial data; Avantor, following the release of…
Key Points Interested in MiMedx Group, Inc? Here are five stocks we like better. MiMedx agreed to acquire Sanara MedTech for $35 per share, adding more than $100 million in surgical revenue and approximately $4 billion in addressable marke…
MIMEDX Announces Second Quarter 2026 Operating & Financial Results
Reports Second Quarter Net Sales of $64 Million Reiterates Full Year Financial Outlook on a Standalone Basis Announces Plans to Acquire Sanara MedTech Management to Host Conference Call Today, July 29, 2026, at 4:30 PM ET MARIETTA, Ga., Ju…
Image source: The Motley Fool. Date Tuesday, March 24, 2026 at 8 a.m. ET Call participants Chief Executive Officer — Seth Yon Chief Financial Officer — Elizabeth Taylor Need a quote from a Motley Fool analyst? Email pr@fool.com Full Confer…
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sanara MedTech, Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI). Such investors are advised to contact Danielle Peyton at newaction@…
Sanara outlines Q2 2026 net revenue of $28.5M-$29.5M while reaffirming $116M-$121M full-year outlook
Earnings Call Insights: Sanara MedTech (SMTI) Q1 2026 MANAGEMENT VIEW * “This was a strong quarter for us, which exceeded our expectations.” (President, CEO & Director Seth Yon) Yon said Q1 2026 was “the first full quarter in which we were…
(RTTNews) - Sanara MedTech Inc. (SMTI), a medical technology company, on Monday released its first quarter financial results. The company specializes in the development and commercialization of technologies that improve clinical outcomes a…
Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)
Net Revenue Growth of 19% and Net Profitability from Continuing Operations of $0.04 Per Fully Diluted Share for the Quarter FORT WORTH, TX, May 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” “Sanara MedTech,” the “Company,” “w…
SMTI Investors Have Opportunity to Join Sanara MedTech Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES, May 07, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sanara MedTech Inc. (“Sanara” or “the Company”) (NASDAQ:…
ICU Medical (ICUI) Tops Q1 Earnings and Revenue Estimates
ICU Medical (ICUI) came out with quarterly earnings of $1.97 per share, beating the Zacks Consensus Estimate of $1.78 per share. This compares to earnings of $1.72 per share a year ago. These figures are adjusted for non-recurring items. T…
Insulet (PODD) Q1 Earnings and Revenues Top Estimates
Insulet (PODD) came out with quarterly earnings of $1.42 per share, beating the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $1.02 per share a year ago. These figures are adjusted for non-recurring items. This…
Image source: The Motley Fool. DATE Tuesday, March 24, 2026 at 8 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Seth Yon Chief Financial Officer — Elizabeth Taylor Full Conference Call Transcript Seth Yon: Thanks, operator, and welcom…
What Makes Sanara Medtech (SMTI) A Compelling Risk-Reward Opportunity?
White Brook Capital Partners, an investment management firm, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter indicated that the first quarter of 2026 was a turnaround period. During…
Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
FORT WORTH, TX, April 14, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company”, “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to imp…
Sanara MedTech, Inc. Investigated by the Portnoy Law Firm
LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Sanara MedTech, Inc., (“Sanara" or the "Company") (NASDAQ:SMTI) investors that the firm has initiated an investigation into possible securities fraud, and may fil…
Sanara MedTech Inc. Q4 2025 Earnings Call Summary - Moby Strategic Realignment and Commercial Execution Achieved a record $103.1 million in net revenue for 2025, a 19% year-over-year increase, driven by the strength of a hybrid commercial…
Sanara MedTech logo Sanara MedTech (NASDAQ:SMTI) reported fourth-quarter and full-year 2025 results highlighting record annual revenue, improved profitability, and progress in its transition to a “pure-play” surgical company following the…
Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates
Sanara MedTech Inc. (SMTI) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.11 per share. This compares to a loss of $0.18 per share a year ago. These figures are adjusted for non-recurring it…
(RTTNews) - Sanara MedTech Inc. (SMTI) announced that its BIASURGE Advanced Surgical Solution has received an Innovative Technology contract from Vizient Inc., the nation's largest provider-driven healthcare performance improvement company…
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device
OraSure TechnologiesOSUR recently announced that it submitted two applications to the FDA seeking approval for its two new at-home tests for sexually transmitted infections (STIs), aiming to expand accessible, home-based diagnostic options…
INVESTOR ALERT: Investigation of Sanara MedTech Inc. (SMTI) Announced by Holzer & Holzer, LLC
ATLANTA, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Sanara MedTech Inc. (“Sanara” or “the Company”) (NASDAQ: SMTI) complied with federal securities laws. On November 11, 2025, Sanara announced that “the…
Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd
FORT WORTH, TX, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to impr…
Sanara MedTech (SMTI) said late Tuesday it is discontinuing operations of its Tissue Health Plus div PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Sanara MedTech signals strategic shift with THP discontinuation and continued surgical growth focus
Earnings Call Insights: Sanara MedTech Inc. (SMTI) Q3 2025 MANAGEMENT VIEW * Seth Yon, President and CEO, opened with, "As the recently appointed President and CEO, I'll begin with a brief introduction and provide some opening thoughts on…
Aurora Cannabis Inc. (ACB) Tops Q2 Earnings and Revenue Estimates
Aurora Cannabis Inc. (ACB) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring…
Bio-Rad Laboratories (BIO) Q3 Earnings Miss Estimates
Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.26 per share, missing the Zacks Consensus Estimate of $2.3 per share. This compares to earnings of $2.01 per share a year ago. These figures are adjusted for non-recurring i…
3 Growth Companies With Insider Ownership Up To 31%
As major stock indexes in the United States continue to reach new heights, driven by significant developments such as Nvidia's landmark $5 trillion market cap and anticipation around Federal Reserve decisions, investors are keenly watching…
Top Growth Companies With Insider Stakes In September 2025
As the U.S. stock market rebounds with major indexes like the Dow Jones and S&P 500 rising after inflation data met expectations, investors are keenly observing how these economic indicators influence broader market trends. In such an envi…
* Sanara MedTech (NASDAQ:SMTI [https://seekingalpha.com/symbol/SMTI]) has named Seth Yon as president and chief executive officer, effective September 15, 2025. * Yon will also join the company’s board. * Yon succeeds Ron Nixon, who will r…
Sanara MedTech Inc. Announces Chief Executive Officer Transition
Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman FORT WORTH, TX, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI)…
Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025
FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to impr…
3 Growth Companies With High Insider Ownership Growing Earnings Up To 106%
As the U.S. stock market continues to navigate through fluctuating inflation data and interest rate expectations, investors are keenly observing companies that demonstrate resilience and potential for growth. In this environment, stocks wi…